ArticleCancer immunology research2013

Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy.

Derek Ng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.